Is smoking a risk factor for progression of chronic renal failure?  by Samuelsson, Ola & Attman, Per-Ola
Letters to the Editor 2597
Table 1. Annual decline in GFR (mL/min 3 1.73 m2 body surfacethe laparoscopic donor nephrectomy, complications de-
area per year) during 3.2 years of follow-up according
crease with surgical experience. There are methods to to smoking status
help shorten this learning curve, including the use of
Moderate Heavy Phand-assist devices and a team approach. Indeed, our Non-smokers smokers smokers (ANOVA)
success has been due to the close working relationship
Men 2.663.9 3.863.7 4.564.6 .0.20
between experienced laparoscopic and transplant sur- N 40 13 4
CGN 2.5 63.9 3.663.5 5.364.6 .0.20geons.
N 33 6 4
Lloyd Ratner, D, Robert Montgomery Data are mean 6 SD.
Definitions are: nonsmokers, never smokers and ex-smokers; moderate smok-and Louis R. Kavoussi
ers, smoking less than 25 g/day; heavy smokers, smoking more than 25 g/day;The Comprehensive Transplant Center
CGN, chronic glomerulonephritis.and Brady Urological Institute
Johns Hopkins Medical Institutions
Baltimore, Maryland, USA
follow-up. Table 1 presents the change in GFR in men,REFERENCES
and in patients with chronic glomerulonephritis (CGN).1. Flowers JL, Jacobs S, Cho E, Morton A, Rosenberger WF, Evans
Although no statistically significant differences were pres-D, Imbembo AL, Bartlett ST: Comparison of open and laparoscopic
live donor nephrectomy. Ann Surg 226:483–489, 1997 ent, these data suggest a role for smoking in these particu-
2. Odland MD, Ney AL, Jacobs DM, Larkin JA, Steffens EK, lar patient categories.Kraatz JJ, Rodriguez JL: Initial experience with laparoscopic live
The possible importance of smoking for progressivedonor nephrectomy. Surgery 126: 4, 603–607, 1999
3. McFayden BV Jr, Vecchio R, Ricardo AE, Mathis CR: Bile renal damage seems to be less clear than in atherosclerosis.
duct injury after laparoscopic cholecystectomy: The United States Further prospective data are needed to determine its roleexperience. Surg Endos 12:315–321, 1998
in chronic renal disease in relation to other well-docu-
mented progression factors such as hypertension, protein-
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To the Editor: Smoking has recently been discussed as
REFERENCES
a risk factor for progression of renal insufficiency. This
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We performed a prospective study of 73 patients with
primary renal disease with the aim of evaluating the role
of renal dyslipidemia for the progression of renal failure
[4]. In a post-hoc analysis, smoking status (at entry) was The filtered complement
related to the decline in glomerular filtration rate (GFR).
There was no significant difference in the progression rate hypothesis
between smokers and nonsmokers during a three-year
To the Editor: In a recent Supplement to Kidney Inter-
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